Skip to main content
. Author manuscript; available in PMC: 2014 Nov 1.
Published in final edited form as: Cancer Prev Res (Phila). 2013 Sep 5;6(11):1162–1170. doi: 10.1158/1940-6207.CAPR-13-0113

Table 3.

Sensitivity and specificity of ALDH1A1 labeling index and clinicopathologic risk factors for metachronous adenoma in replication set

Model % correct Sensitivity Specificity False positive False negative
Age, gender, any advanced lesion 22.4 42.5 0 67.9 100
 plus ALDH1A1 (continuous) 56.6 57.5 55.6 41 45.9
 plus ALDH1A1 (≥ median) 57.9 60 55.6 40.0 44.4
 plus ALDH1A1 (≥ mean) 50 52.5 47.2 47.5 52.8
 plus ALDH1A1 (≥22.4%) 63.2 52.5 75.0 30 41.3